Synthesis of Bis-Aminoazirines and their Application in Peptide Synthesis by Köttgen, P et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2009
Synthesis of Bis-Aminoazirines and their Application in Peptide Synthesis
Köttgen, P; Linden, A; Heimgartner, H
Abstract: The ’cyclohexane-bridged’ bis-(3-amino-2H-azirines) cis- and trans-N,N’-dimethyl-N,N’-diphenyl-
1,7-diazadispiro[2.2.2.2]deca-1,7-diene-2,8-diamine (cis-21 and trans-21) were synthesized from the corre-
sponding bis-thioamide 20 by consecutive treatment with COCl2, 1,4-diazabicyclo[2.2.2]octane (DABCO)
and NaN3. The reaction of these bis-azirines with different natural ￿-amino acids gave peptide amides
23. In addition, hydrolysis of the C-terminal amide groups of 23c and subsequent coupling with the Aib
synthon 2, i.e., 2,2,N-trimethyl-N-phenyl-2H-azirin-3-amine, showed the applicability of building blocks
21 for peptide synthesis and peptide chain ligation.
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-23964
Published Version
Originally published at:
Köttgen, P; Linden, A; Heimgartner, H (2009). Synthesis of Bis-Aminoazirines and their Application in
Peptide Synthesis. Acta Chimica Slovenica, 56(3):591-602.
591Acta Chim. Slov. 2009, 56, 591–602
Köttgen et al.:  Synthesis of Bis-Aminoazirines and their Application in Peptide Synthesis
Scientific paper
Synthesis of Bis-Aminoazirines 
and their Application in Peptide Synthesis
Peter Köttgen, Anthony Linden and Heinz Heimgartner*
Institute of Organic Chemistry, University of Zürich, Winterthurerstrasse 190, 
CH-8057 Zürich, Switzerland
* Corresponding author: E-mail: heimgart@oci.uzh.ch
Received: 29-09-2008
Dedicated to Professor Branko Stanovnik on the occasion of his 70th birthday
Abstract
The šcyclohexane-bridged’ bis-(3-amino-2H-azirines) cis- and trans-N,N’-dimethyl-N,N’-diphenyl-1,7-diazadispi-
ro[2.2.2.2]deca-1,7-diene-2,8-diamine (cis-21 and trans-21) were synthesized from the corresponding bis-thioamide 20
by consecutive treatment with COCl2, 1,4-diazabicyclo[2.2.2]octane (DABCO) and NaN3. The reaction of these bis-azi-
rines with different natural α-amino acids gave peptide amides 23. In addition, hydrolysis of the C-terminal amide
groups of 23c and subsequent coupling with the Aib synthon 2, i.e., 2,2,N-trimethyl-N-phenyl-2H-azirin-3-amine, sho-
wed the applicability of building blocks 21 for peptide synthesis and peptide chain ligation.
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1. Introduction
Tools for the reduction of the conformational free-
dom of a protein and, therefore, for controlling its three-
dimensional structure are of considerable interest in orga-
nic, medicinal and biochemistry.1,2 Conformational con-
straints can be achieved by incorporation of non-protein
amino acids into the polypeptide chain.3 Substitution of
the H-atom at C(α) of a natural amino acid is one of the
widest spread strategies for backbone modification lea-
ding to an enhanced tendency to form secondary structu-
res such as β-turns or helices.4–12 The most well-known
α,α-disubstituted α-amino acid (2,2-disubstituted glyci-
ne) is aminoisobutyric acid (Aib), which is ubiquitous in
natural peptaibols and responsible for the helical confor-
mation of these oligopeptides with antibiotic properties.13
Figure 1. Different types of 2H-azirin-3-amines.
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The preferred formation of the 310-helical conformation
has been demonstrated for several Aib-containing oligo-
peptides.14–20
A useful strategy for the introduction of these disub-
stituted amino acids into peptides is the šazirine/oxazolo-
ne method’,18–23 in which 2H-azirin-3-amines 1 are used
as amino acid synthons. The reaction of the latter, e.g., the
Aib synthon 2, with amino or peptide acids leads to pepti-
de amides, the terminal amide groups of which can be
hydrolyzed selectively.
Based on the first synthesis of Rens and Ghosez,24
numerous 2H-azirin-3-amines have been prepared,22,25–27
including enantiomerically pure chiral compounds,28,29
spirocyclic8a,30 and heterospirocyclic compounds (e.g.
3),31,32 as well as dipeptide synthons of type 4 and 518,33–35
(Figure 1). These molecules have been applied success-
fully in the synthesis of peptaibols,18–20,23,36 endothiopep-
tides,37–40 cyclic peptides,41–43 and cyclic depsipepti-
des.44–47 Furthermore, the crystal structure of the 1,4-
bis(2,2dimethyl-2H-azirin-3-yl)piperazine (6) has been
published,48 without disclosing its synthesis and reac-
tions.
A very general and effective way of introducing a
global constraint into a peptide chain is the formation of a
covalent bond between distant parts in the sequence, e.g.,
by formation of disulfide bridges between cysteine resi-
dues.49 Because this might possibly also be achieved bet-
ween two carboxylic acid functions by using a bis-(3-ami-
no-2H-azirine) of type 7 (Scheme 1), it was of interest to
develop a synthesis of such molecules by using similar
methods as described for the monomeric analogues.24,50–52
In the present paper we report the synthesis of the
bis-(3-amino-2H-azirines) cis-21 and trans-21, represen-
ting the first examples of this new class of molecules.
Reactions with several N-protected α-amino acids confir-
med that these new building blocks are suitable for pepti-
de synthesis.
2. Results and Discussion
In preliminary studies we elucidated the appropria-
teness of bis-(N-methyl-N-phenylamides) for azirine
synthesis and attempted the preparation of compounds
with two (3-amino-2H-azirine) structures linked together
by an alkyl chain. The preparation of 2,4-dimethylpenta-
nedioic acid bis-(methylphenylamide) (9) and 2,7-di-
methyloctanedioic acid bis-(methylphenylamide) (10)
was achieved via α-alkylation of two equivalents of N-
methyl-N-phenylpropanamide (8) with dibromomethane
or 1,4-dibromobutane, respectively (Scheme 2). Since the
conversion of these compounds into the corresponding
bis-azirines according to the procedure of Villalgordo and
Heimgartner52 was not successful, 9 and 10 were conver-
ted into the corresponding thioamides 11 and 12 by reac-
tion with P2S5 and hexamethyldisiloxane (HMDO).
53 The-
se are the required starting materials for a synthesis analo-
gous to the procedure described earlier.50,51 In the case of
11, consecutive treatment with COCl2 in CH2Cl2, evapora-
tion of the solvent, dissolution of the residue in THF, addi-
tion of 1,4-diazabicyclo[2.2.2]octane (DABCO), filtra-
tion, and reaction of the filtrate with NaN3 gave 4H-
Scheme 1
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the corresponding mono-azirine 14 and the bis-azirine 15.
In addition, an IR-absorption at 1750 cm–1, which is cha-
racteristic for 2H-azirin-3-amines, was observed. Alt-
hough the desired compound could not be isolated, it see-
med possible that bis-(3-amino-2H-azirines) could be
synthesized by this method using phosgene.
Scheme 2
thiopyran-2,6-diamine 13 in quantitative yield, instead of
the desired bis-azirine.
A plausible mechanism for the formation of 13 is
shown in Scheme 3. The key step is the cyclization of the
mono-chloriminium salt 16 via nucleophilic attack of the
neighboring thioamide group to give the bis-iminium salt
17, which stabilizes by twofold deprotonation. It is likely
that this side reaction is favored in the case of the forma-
tion of a six-membered ring.
After the treatment of 12 under the same conditions,
no product could be isolated due to decomposition of the
crude material during the purification process. However,
analysis of the crude product by mass spectrometry sho-
wed the absence of a nine-membered cyclization product
analogous to 13, but indicated the presence of a mixture of
Scheme 3
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Since in the case of 15 the formation of different ste-
reoisomers is possible, which probably would be difficult to
separate because of the flexibility of the molecule, we deci-
ded to use a cyclohexane ring as a symmetric and less fle-
xible connection between the two three-membered hete-
rocycles. The preparation of the required starting material
20 for the azirine synthesis was performed starting with the
commercially available cis/trans-1,4-cyclohexanedicar-
boxylic acid 18. Conversion to the bis-(N-methyl-N-phenyl-
amide) 19 (cis/trans mixture) via the bis-acyl chloride and
subsequent thionation with P2S5/HMDO gave cyclohexane-
1,4-dicarboxylic acid bis-(N-methyl-N-phenylthioamide)
20.* Treatment of the latter with COCl2, DABCO and NaN3
as described above yielded a mixture of cis-21 and trans-
21. These isomers were separated by means of column
chromatography and were obtained as solid products in
31% and 39% yield, respectively (Scheme 4).
Recrystallization of cis-21 from a mixture of
CH2Cl2, acetone, hexane, and Et2O by slow evaporation of
the solvent gave crystals that were sufficiently adequate
for a crude X-ray crystal structure determination, which
allowed the essential conformation of the molecule to be
established. The molecular structure of cis-21 is shown in
Figure 2.
The cyclohexane ring shows the chair conformation
with the unsubstituted N(9) and N(16) atoms of the aziri-
Scheme 4
* NMR spectroscopy did not give any indication for the presence of two diastereoisomers. As the reaction pathway for the synthesis of 3-amino-2H-azi-
rines involves intermediates with a sp2-C(α) atom of the thioamide,22 the stereochemical properties of the starting material are irrelevant.
Figure 2. ORTEP Plot54 of the molecular structure of cis-21 (50% probability ellipsoids, arbitrary numbering of the atoms).
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ne rings cis to one another and in pseudo-equatorial and
pseudo-axial orientations, respectively.
To examine the reactivity of the new bis-(3-amino-
2H-azirines) cis-21 and trans-21, they were reacted with
Z-protected L-alanine (22a)** in CHCl3 which lead to the
corresponding peptides 23a (Scheme 5). Compound
trans-21 was chosen for reactions with other natural α-
amino acids, which bear different protecting groups, i.e.,
Z-Phe-OH (22b), Fmoc-Leu-OH (22c), and Z-Lys(Boc)-
OH (22d), leading to peptides 23b–d. In an analogous
manner, the reaction of trans-21 with acetic acid gave the
corresponding trans-1,4-bis(acetylamino)cyclohexane-
1,4-dicarboxamide 24 (not shown in Scheme 5). All reac-
tions proceeded smoothly at room temperature to give the
products in high to very high yields (81–97%) without the
formation of any side products.
The terminal amide groups of peptide 23c were se-
lectively hydrolyzed using the standard procedure (3N
HCl in water/THF) to give the peptide 25c with unprotec-
ted C-termini. The latter was subsequently reacted with
the Aib synthon 2 to yield the extended peptide 26c, sho-
wing that bis-azirine trans-21 (as a representative of both
diastereoisomers) is a convenient building block for the
šazirine/oxazolone method’ (Scheme 6).
3. Conclusions
The first examples of bis-(2H-azirin-3-amines) con-
nected via the C(2)-atoms, i.e., cis- and trans-21, were
prepared in good yields from the corresponding bis-(thio-
amide) by using the šphosgene methodology’. Furthermo-
re, it has been shown that the reactivity of these bis-aziri-
nes is similar to that of known 2H-azirin-3-amines and,
therefore, they can be used as synthons of bis-(amino
acids) in the preparation of ligated peptide chains.
Scheme 5
** Abbreviations: Z = benzyloxycarbonyl, Boc = tert-butyloxycarbonyl, Fmoc = (9H-fluoren-9-yl)methoxycarbonyl
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4. Experimental
4. 1. General Procedures
Melting points were determined on a Büchi 540 ap-
paratus; they are uncorrected. IR spectra were recorded on
a Perkin-Elmer spectrum one spectrophotometer; absorp-
tion bands in cm–1. 1H NMR (300 MHz) and 13C NMR
(75.5 MHz) spectra were obtained on a Bruker ARX-300
instrument at room temperature (r.t.); TMS was used as
internal standard, δ in ppm. Mass spectra (MS) were re-
corded on a Finnigan SSQ-700 spectrometer for chemical
ionization (CI, with NH3) and electrospray ionization
(ESI, in MeOH + NaI), and on a Finnigan MAT95 spec-
trometer for HR-MS (CI). Thin-layer chromatography
(TLC) was performed on Merck TLC aluminium sheets,
silica gel 60 F254, and flash chromatography (CC) on Ueti-
kon-Chemie šChromatographiegel C-560’. The Aib syn-
thon 2 was prepared according to ref. 52, and amide 8 was
prepared according to ref. 30. All other products used we-
re commercially available.
4. 1. 1. General Procedure 1 (GP1)
To a solution of diisopropylamine (2.16 ml, 15.3
mmol) in THF (30 ml) at –80 °C was added butyllithium
(8.8 ml, 1.6M in hexane, 14.1 mmol), and the mixture was
stirred for 30 min. Then, amide 8 (2.1 g, 12.8 mmol) in THF
(5 ml) was added, and after 30 min stirring at –80 °C, the
corresponding dibromoalkane (6.4 mmol) was added. The
reaction mixture was allowed to warm up to r.t. slowly. A sa-
turated aqueous NH4Cl-solution (40 ml) was added and the
aqueous layer extracted with Et2O (2 × 30 ml). The combi-
ned organic fractions were washed with water (40 ml) and
brine (20 ml). After drying over MgSO4, filtration, and eva-
poration of the solvent, the residue was purified by CC.
4. 1. 2. General Procedure 2 (GP2)
A mixture of the corresponding amide, P2S5 and he-
xamethyldisiloxane (HMDO) in CHCl3 was heated under
reflux until complete conversion of the amide was obser-
ved by TLC. After cooling to r.t., the solvent was evapora-
ted and the residue purified by CC.
4. 1. 3. General Procedure 3 (GP3)
To a solution of the corresponding thioamide (3.81
mmol) and 3 drops of DMF in CH2Cl2 (20 ml) at 0 °C was
added phosgene*** (20% solution in toluene, 9 ml, 18.1
mmol). The mixture was stirred at r.t. for 60 min and was
then concentrated under reduced pressure. THF (40 ml)
and DABCO (852 mg, 7.62 mmol) were added and the
mixture was stirred for 30 min at r.t. The formed precipita-
tion was filtered under nitrogen, and after the addition of
Scheme 6
*** Warning: Phosgene is a highly toxic gas (b.p. 8 °C), which has to be
handled with extreme caution. Its solution in toluene is more safe and
was used in a closed system.
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DMF (30 ml) and NaN3 (2.0 g, 30.8 mmol), the suspen-
sion was stirred for 60 h at ambient temperature. Filtration
and evaporation of the solvent gave the crude product that
was purified as indicated.
4. 1. 4. General Procedure 4 (GP4)
A solution of azirine cis-21 or trans-21 and the cor-
responding carboxylic acid in CHCl3 was stirred at r.t. un-
til complete conversion of the starting materials was ob-
served (TLC). The mixture was then washed three times
with saturated aqueous NaHCO3-solution and dried over
MgSO4. Evaporation of the solvent gave the crude product
that was purified as indicated.
4. 2. Attempted Synthesis of Bis-azirines 
of Type 15
2,4,N,N’-Tetramethyl-N,N’-diphenylpentanedioic Acid
Diamide (9). Prepared according to GP1; with dibromo-
methane (1.11 g, 0.45 ml, 6.4 mmol), CC (SiO2, hexa-
ne/AcOEt 1:1, then 2:3). Yield: 950 mg (44%) of amide 9.
White powder; mp 83 °C. IR (KBr): νmax 3291w, 3052w,
2970s, 2931m, 2871w, 1651s, 1594s, 1494s, 1455s,
1425s, 1387s, 1329m, 1273s, 1113s, 1026m, 773m, 703s
cm–1. 1H NMR (CDCl3): δ 0.79 (6H, d, J = 6.7 Hz, 2
MeCH); 1.59–1.64 (2H, m, CH2); 2.37–2.45 (2H, m, 2
MeCH); 3.28 (6H, s, 2 MeN); 7.19–7.47 (10H, m, 2 Ph).
13C NMR (CDCl3): δ 16.9 (q, 2 MeCH); 33.6 (d, 2
MeCH); 37.3 (q, 2 MeN); 37.8 (t, CH2); 127.3, 127.6,
129.6 (3d, 10 arom. CH); 143.9 (s, 2 arom. CN); 176.0 (s,
2 CO). ESI-MS (m/z): 361 (100, [M + Na]+).
2,7,N,N’-Tetramethyl-N,N’-diphenyloctanedioic Acid
Diamide (10). Prepared according to GP1; with 1,4-di-
bromobutane (1.38 g, 0.76 ml, 6.4 mmol), CC (SiO2, he-
xane/AcOEt 3:2). Yield: 1.92 g (79%) of amide 10. White
powder; mp 55–56 °C. IR (KBr): νmax 3041w, 2930m,
2861w, 1650s, 1593s, 1493s, 1464m, 1386m, 1263m,
1117m, 1031m, 776m, 702s cm–1. 1H NMR (CDCl3): δ
0.98 (6H, d, J = 6.7 Hz, 2 MeCH); 0.98–1.29, 1.50–1.69
(6H + 2H, 2m, 4 CH2); 2.26–2.38 (2H, m, 2 MeCH); 3.25
(6H, s, 2 MeN); 7.12–7.15, 7.28–7.43 (4H + 6H, 2m, 2
Ph). 13C NMR (CDCl3): δ 18.1 (q, 2 MeCH); 27.5, 34.4
(2t, 4 CH2); 36.3 (d, 2 MeCH); 37.2 (q, 2 MeN); 127.3,
127.5, 129.6 (3d, 10 arom. CH); 144.1 (s, 2 arom. CN);
176.7 (s, 2 CO). ESI-MS (m/z): 403 (100, [M + Na]+).
2,4,N,N’-Tetramethyl-N,N’-diphenylpentane-bis-thi-
oic Acid Diamide (11). Prepared according to GP2; with
amide 9 (1.01 g, 3.0 mmol), P2S5 (1.28 g, 5.7 mmol) and
HMDO (3.97g, 5.2 ml, 24.4 mmol) in CHCl3 (20 ml), 14
h, CC (SiO2, hexane/AcOEt 6:1). Yield: 930 mg (84%) of
thioamide 11. Yellowish powder; mp 110–112 °C. IR
(KBr): νmax 3043w, 2973m, 2925m, 2861w, 1592m,
1492s, 1463s, 1379s, 1343m, 1268m, 1106s, 1069m,
992s, 777m, 771m, 699s cm–1. 1H NMR (CDCl3): δ 0.74
(6H, d, J = 6.4 Hz, 2 MeCH); 1.83 (2H, t, J = 6.9 Hz,
CH2); 2.73–2.80 (2H, m, 2 MeCH); 3.69 (6H, s, 2 MeN);
7.34–7.49 (10H, m, 2 Ph). 13C NMR (CDCl3): δ 20.2 (q, 2
MeCH); 40.5 (t, CH2); 44.9 (d, 2 MeCH); 45.4 (q, 2 Me-
N); 125.5, 128.4, 129.9 (3d, 10 arom. CH); 145.3 (s, 2
arom. CN); 211.1 (s, 2 CS). ESI-MS (m/z): 393 (100, [M +
Na]+).
2,7,N,N’-Tetramethyl-N,N’-diphenyloctane-bis-thioic
Acid Diamide (12). Prepared according to GP2; with
amide 10 (1.14 g, 3.0 mmol), P2S5 (1.28 g, 5.7 mmol) and
HMDO (3.97g, 5.2 ml, 24.4 mmol) in CHCl3 (20 ml), 14
h, CC (SiO2, hexane/AcOEt 10:1). Yield: 408 mg (33%)
of thioamide 12. Yellowish powder; mp 109 °C. IR (KBr):
νmax 3427w, 2957m, 2925m, 2858m, 1694m, 1492s,
1461s, 1443s, 1383s, 1272m, 1110m, 1033s, 773m, 700s
cm–1. 1H NMR (CDCl3): δ 1.08 (6H, d, J = 6.6 Hz, 2
MeCH): 0.89–1.09, 1.24–1.39, 1.60–1.82 (4H + 2H + 2H,
3m, 4 CH2); 2.56–2.70 (2H, m, 2 MeCH); 3.72 (6H, s, 2
MeN); 7.07–7.14, 7.36–7.48 (4H + 6H, 2m, 2 Ph). 13C
NMR (CDCl3): δ 22.1 (q, 2 MeCH); 27.6, 38.1 (2t, 4
CH2); 43.9 (d, 2 MeCH); 45.4 (q, 2 MeN); 125.4, 128.3,
129.9 (3d, 10 arom. CH); 145.62 (s, 2 arom. CN); 212.1
(s, 2 CS). ESI-MS (m/z): 435 (100%, [M + Na]+).
3,5,N,N’-Tetramethyl-N,N’-diphenyl-4H-thiopyran-
2,6-diamine (13). Prepared according to GP3; with thio-
amide 11 (1.41 g), CC (SiO2, hexane/AcOEt 4:1). Yield:
1.23 g (96%) of 13. Orange oil. IR (film): νmax 3026w,
2985w, 2913w, 2903m, 2810w, 1598s, 1577m, 1499s,
1451m, 1336s, 1297m, 1236m, 1108m, 1034m, 1001m,
909m, 748s cm–1. 1H NMR (CDCl3): δ 1.69 (6H, s, 2 Me);
3.05 (6H, s, 2 MeN); 6.72–6.80, 7.15–7.22 (6H + 4H, 2m,
2 Ph). 13C NMR (CDCl3): δ 18.7 (q, 2 Me); 37.4 (q, 2 Me-
N); 40.0 (t, CH2); 113.0, 117.6, 128.9 (3d, 10 arom. CH);
125.1, 133.8, 147.0 (3s, 2 C=C + 2 arom. CN). CI-MS
(m/z): 337 (100, [M + H]+), 91 (5%).
Attempted synthesis of 15. Acoording to GP3, thioamide
12 (1.57 g), was treated with COCl2, DABCO, and NaN3;
attempted isolation led to decomposition. IR (film, crude
mixture): νmax 3398m, 2933m, 2857w, 2222w, 2155m,
2029w, 1750s, 1654m, 1599s, 1501s, 1460w, 1113m,
755m cm–1. ESI-MS of the crude mixture (m/z): 403 (84,
[M(10) + Na]+), 400 (100, [M(14) + Na]+), 397 (34, M(15)
+ Na]+).
4. 3. Synthesis of cis- and trans-N,N’-
Dimethyl-N,N’-diphenylyclohexane-1,7-
diazadispiro[2.2.2.2]deca-1,7-
diene-2,8-diamine (cis-21 and trans-21) 
N,N’-Dimethyl-N,N’-diphenylclohexane-1,4-dicarbox-
amide (19). A solution of 1,4-cyclohexanedicarboxylic
acid (cis/trans mixture, 10.0 g, 58 mmol) in SOCl2 (100 ml)
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was heated to reflux for 6 h. The mixture was concentra-
ted under reduced pressure and the residue dried in high
vacuum. Ethyl acetate (300 ml) and, after cooling to 0 °C,
triethylamine (13.1 g, 18.2 ml, 130 mmol) and N-methy-
lanilin (13.9 g, 14.1 ml, 130 mmol) were added slowly.
The mixture was stirred at r.t. for 16 h; then water (200
ml) was added. The organic layer was extracted with 1N
aqueous HCl-solution (3 × 100 ml), 1N aqueous NaOH-
solution (3 × 100 ml), and brine (50 ml). Evaporation of
the solvent and crystallization from toluene gave bis-ami-
de 19 (mixture of 2 diastereoisomers, ratio ca. 1:1). White
powder; mp 156–158 °C. IR (KBr): νmax 2946m, 2920m,
2858w, 1644s, 1592m, 1495m, 1451w, 1417w, 1388m,
1270m, 1117m, 779w, 702s cm–1. 1H NMR (CDCl3): δ
1.18–1.41, 1.54–2.03, 2.10–2.41 (4H + 4H + 2H, 3m, 4
CH2 + 2 CH); 3.19, 3.22 (6H, 2s, 2 MeN); 7.10–7.46
(10H, m, 2 Ph). 13C NMR (CDCl3): δ 26.0, 28.2 (2t, 4
CH2); 37.4, 37.6 (2q, 2 MeN); 40.2 (d, 2 CH); 126.2,
127.1, 127.3, 127.9, 129.6, 129.8 (6d, 10 arom. CH);
144.0, 144.6 (2s, 2 arom. CN); 175.7, 175.9 (2s, 2 CO).
ESI-MS (m/z): 373 (100, [M + Na]+). Anal. Calcd. for
C22H26N2O2 (350.20): C, 75.40; H, 7.48; N, 7.99. Found:
C, 75.31; H, 7.22; N, 7.78.
Trans-N,N-Dimethyl-N,N-diphenylcyclohexane-1,4-
biscarbothioamide (20). Prepared according to GP2;
with amide 19 (2.1g, 6.0 mmol), P2S5 (1.28 g, 5.7 mmol),
and HMDO (3.97g, 5.2 ml, 24.4 mmol) in CHCl3 (20 ml),
3 h, CC (SiO2, CH2Cl2). Yield: 1.93 g (84%) of thioamide
20. Yellowish powder; mp 249–250 °C. IR (KBr): νmax
3043w, 2947m, 2923m, 2856m, 1593w, 1586w, 1492s,
1467s, 1444s, 1380s, 1358m, 1269m, 1179m, 1101m,
1050m, 766m, 751m, 694s cm–1. 1H NMR (CDCl3): δ
1.53–1.64 (8H, m, 4 CH2); 2.53–2.61 (2H, m, 2 CH); 3.65
(6H, s, 2 MeN); 7.08–7.12, 7.40–7.53 (4H + 6H, 2m, 2
Ph). 13C NMR (CDCl3): δ 32.5 (t, 4 CH2); 45.6 (d, 2 CH);
47.9 (q, 2 MeN); 125.1, 128.7, 130.0 (3d, 10 arom. CH);
145.4 (s, 2 arom. CN); 210.3 (s, 2 CS). CI-MS (m/z): 383
(100, [M + H]+). Anal. Calcd. for C22H26N2S2 (382.59): C,
69.07; H, 6.85; N, 7.32; S, 16.76. Found: C, 69.02; H,
6.48; N, 7.21; S, 16.79.
Cis- and trans-N,N’-Dimethyl-N,N’-diphenyl-1,7-di-
azadispiro[2.2.2.2]deca-1,7-diene-2,8-diamine (cis-21
and trans-21). Prepared according to GP3; with thioami-
de 20 (1.45 g), CC (SiO2, hexane/AcOEt 1:2, then 1:5).
Yields: 405 mg (31%) of cis-21 and 510 mg (39%) of
trans-21.
Data of cis-21: Yellowish powder; mp 110–112 °C.
IR (KBr): νmax 3399w, 2944m, 2909m, 2212w, 1759s,
1647m, 1599s, 1500s, 1354m, 1279s, 1112m, 1009m,
949m, 890w, 759s, 693m cm–1. 1H NMR (CDCl3): δ
1.62–2.21 (8H, m, 4 CH2); 3.51 (6H, s, 2 MeN);
7.02–7.50 (10H, m, 2 Ph). 13C NMR (CDCl3): δ 34.2 (t, 4
CH2); 117.4, 123.6, 129.2 (3d, 10 arom. CH); 142.7 (s, 2
arom. CN); 167.9 (s, 2 C=N); MeN and spiro-C could not
be detected. CI-MS (m/z): 345 (100, [M + H]+), 238 (19),
108 (41). HR-CIMS (m/z): 345.2082 ([M + H]+); calcd.
for C22H25N4: 345.2079 (δ = 0.8 ppm).
Crystals for an X-ray crystal-structure determination
were grown from a solution of cis-21 in a mixture of
CH2Cl2, acetone, hexane, and Et2O by slow evaporation of
the solvent.
Data of trans-21: Yellowish powder; mp 98–99 °C.
IR (KBr): νmax 3433,w 2950m, 2929m, 2905m, 2827m,
1744s, 1596s, 1503s, 1320m, 1235m, 1189m, 1101s,
1034w, 752s, 690m cm–1. 1H NMR (CDCl3): δ 1.31–1.39,
2.54–2.63 (4H + 4H, 2m, 4 CH2); 3.49 (6H, s, 2 MeN);
7.11–7.21, 7.39–7.48 (4H + 6H, 2m, 2 Ph). 13C NMR
(CDCl3): δ 33.2 (t, 4 CH2); 115.8, 123.1, 129.4 (3d, 10
arom. CH); 142.2 (s, 2 arom. CN); 176.8 (s, 2 C=N); Me-
N and spiro-C could not be detected. CI-MS (m/z): 345
(100, [M + H]+), 238 (33), 108 (10). HR-CIMS (m/z):
345.2088 ([M + H]+); calcd. for C22H25N4: 345.2079 (δ =
2.6 ppm).
4. 4. Reactions of cis-21 and trans-21 
with Amino Acids
Benzyl Cis-[(S)-1-(4-{(S)-2-[(Benzyloxycarbonyl)ami-
no]propanoylamino}-1,4-bis(N-methyl-N-phenylcar-
bamoyl)cyclohexylcarbamoyl)ethyl]carbamate (cis-
23a). Prepared according to GP4; with cis-21 (30 mg,
0.087 mmol) and Z-Ala-OH (42 mg, 0.19 mmol) in CHCl3
(5 ml), 2 h, CC (SiO2, hexane/AcOEt 1:3). Yield: 63 mg
(91%) of cis-23a. Yellowish powder; mp 177–178 °C. IR
(KBr): νmax 3295s, 3061m, 2975m, 2936m, 1722s, 1674s,
1630s, 1592m, 1493s, 1453m, 1386m, 1239s, 1098m,
1069m, 738m, 698s cm–1. 1H NMR (d6-DMSO): δ 1.20
(6H, d, J = 6.9 Hz, 2 MeCH); 1.60–1.90, 2.05–2.30 (4H +
4H, 2m, 4 CH2); 3.17 (6H, s, 2 MeN); 3.95–4.08 (2H, m,
2 MeCH); 5.01, 5.05 (4H, 2d, J = 12.7 Hz, 2 CH2O);
7.06–7.41 (22H, m, 4 Ph + 2 NH); 7.88 (2H, br, 2 NH).
13C NMR (d6-DMSO): δ 18.7 (q, 2 MeCH); 28.6, 29.1 (2t,
4 CH2); 39.8 (q, 2 MeN); 49.5 (d, 2 MeCH); 57.8 (s, 2
(CH2)2C); 65.1 (t, 2 CH2O); 126.4, 127.3, 127.5, 127.6,
128.2, 128.7 (6d, 20 arom. CH); 137.1 (s, 2 arom. C);
145.4 (s, 2 arom. CN); 155.5 (s, 2 O-CO-N); 171.2, 171.5
(2s, 4 CO). ESI-MS (m/z): 813 (100, [M + Na]+). [α]25D:
–7.7 (c 0.5, MeOH). Anal. Calcd. for C44H50N6O8·0.5 H2O
(799.92): C, 66.07; H, 6.42; N, 10.51. Found: C, 66.11; H,
6.40; N, 10.31.
Benzyl Trans- [(S)-1-(4-{(S)-2-[(Benzyloxycarbonyl)
amino]propanoylamino}-1,4-bis(N-methyl-N-phenyl-
carbamoyl)cyclohexylcarbamoyl)ethyl]carbamate
(trans-23a). Prepared according to GP4; with trans-21
(30 mg, 0.087 mmol) and Z-Ala-OH (43 mg, 0.19 mmol)
in CHCl3 (5 ml), 2 h, CC (SiO2, hexane/AcOEt 1:3).
Yield: 67 mg (97%) of trans-23a. White powder; mp 195
°C. IR (KBr): νmax 3329s, 3033m, 2937m, 1717s, 1674s,
1627s, 1593m, 1528s, 1493s, 1453s, 1378m, 1248s,
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1070m, 739m, 700s cm–1. 1H NMR (CDCl3): δ 1.25 (6H,
d, J = 6.7 Hz, 2 MeCH); 1.89–2.24 (8H, m, 4 CH2); 3.14
(6H, s, 2 MeN); 3.53 (2H, br, 2 NH); 5.11–5.30 (6H, m, 2
CH2O + 2 MeCH); 6.02 (2H, br, 2 NH); 7.07–7.48 (20H,
m, 4 Ph). 13C NMR (CDCl3): δ 17.3 (q, 2 MeCH); 27.1,
28.0 (2t, 4 CH2); 41.1 (q, 2 MeN); 49.9 (d, 2 MeCH); 58.9
(s, 2 (CH2)2C); 67.4 (t, 2 CH2O); 126.8, 127.6, 128.1,
128.3, 128.4, 129.4 (6d, 20 arom. CH); 136.2 (s, 2 arom.
C); 144.9 (s, 2 arom. CN); 156.1 (s, 2 O-CO-N); 171.1,
171.8 (2s, 4 CO). ESI-MS (m/z): 813 (100, [M + Na]+).
[α]25D: –9.6 (c 0.6, MeOH). Anal. Calcd. for
C44H50N6O8·0.5 H2O (799.92): C, 66.07; H, 6.42; N,
10.51. Found: C, 66.17; H, 6.39; N, 10.42.
Benzyl Trans-[(S)-1-(4-{(S)-2-[(Benzyloxycarbonyl)
amino]-3-phenylpropanoylamino}-1,4-bis-(N-methyl-
N-phenylcarbamoyl)cyclohexylcarbamoyl)-2-phenyl-
ethyl]carbamate (trans-23b). Prepared according to
GP4; with trans-21 (100 mg, 0.29 mmol) and Z-Phe-OH
(190 mg, 0.64 mmol) in CHCl3 (10 ml), 2 h, CC (SiO2,
CH2Cl2/MeOH 25:1). Yield: 220 mg (81%) of trans-23b.
White powder; mp 177–178 °C. IR (KBr): νmax 3305s,
3061m, 3030m, 2948m, 1954m, 1717s, 1661s, 1627s,
1592m, 1493s, 1454s 1381m, 1255s, 1148m, 1032m,
748m, 698s cm–1. 1H NMR (d6-DMSO): δ 1.71–2.02 (8H,
m, 4 CH2); 2.63 (2H, t, J = 13.1 Hz, 2 PhCH); 2.89 (2H,
dd, J1 = 3.6 Hz, J2 = 13.1 Hz, 2 PhCH); 3.03 (s, 6H, 2 Me-
N); 4.11–4.21 (2H, m, 2 CHN); 4.79, 4,87 (4H, 2d, J =
12.7 Hz, 2 CH2O); 6.96–7.27 (m, 30H, 6 Ph); 7.39 (2H, d,
J = 8.7 Hz, 2 NH); 7.86 (2H, s, 2 NH). 13C NMR (d6-
DMSO): δ 26.5, 26.9 (2t, 4 CH2); 37.2 (t, 2 PhCH2); 39.7
(q, 2 MeN); 57.8 (s, 2 (CH2)2C); 65.2 (t, 2 PhCH2O);
126.1, 126.3, 127.1, 127.3, 127.5, 127.9, 128.1, 128.8,
129.1 (9d, 30 arom. CH); 136.9, 137.9 (2s, 4 arom. C);
145.5 (s, 2 arom. C); 155.9 (s, 2 O-CO-N); 170.7, 172.1
(2s, 2 CO). ESI-MS (m/z): 981 (8, [M + K]+), 965 (100,
[M + Na]+). [α]25D: –12.1 (c 0.6, MeOH). Anal. Calcd. for
C56H58N6O8·0.5 H2O (952.12): C, 70.64; H, 6.25; N, 8.83.
Found: C, 70.45; H, 6.19; N, 8.61.
(9H-Fluoren-9-yl)methyl Trans-((S)-1-{4-[(S)-2-{[(9H-
Fluoren-9-yl)methoxy]carbonylamino}-4-(methylpen-
tanoyl)amino]-1,4-bis(N-methyl-N-phenylcarba-
moyl)cyclohexylcarbamoyl}-3-methylbutyl)carbama-
te (trans-23c). Prepared according to GP4; with trans-21
(100 mg, 0.29 mmol) and Fmoc-Leu-OH (226 mg, 0.64
mmol) in CHCl3 (10 ml), 2 h, CC (SiO2, CH2Cl2/MeOH
33:1). Yield: 268 mg (88%) of trans-23c. White powder;
mp 218 °C. IR (KBr): νmax 3304s, 3064m, 3039m, 2955s,
2868m, 1724s, 1653s, 1629s, 1593m, 1524s, 1493s,
1449s, 1383m, 1331m, 1252s, 1033m, 758m, 738s, 700m
cm–1. 1H NMR (d6-DMSO): δ 1.04, 1.07 (12H, 2d, J =
6.6Hz, 2 Me2CH); 1.52–1.89, 2.04–2.30 (6H + 8H, 2m, 2
Me2CHCH2 + 2 CH2C); 3.32 (6H, s, 2 MeN); 4.20–4.57
(8H, m, 2 CHCH2O + 2 NCHCO); 7.20–8.11 (30H, m, 2
fluorenyl + 2 Ph + 4 NH). 13C NMR (d6-DMSO): δ 21.3,
23.0 (2q, 2 Me2CH); 24.1 (d, 2 Me2CH); 26.5, 26.6 (2t, 2
(CH2)2C); 39.6 (q, 2 MeN); 40.4 (t, Me2CHCH2); 46.5 (d,
2 CHCH2O); 52.7 (d, 2 NCHCO); 57.6 (s, 2 (CH2)2C);
65.5 (t, 2 CH2O); 119.9, 120.1, 125.1, 125.2, 126.3, 127.0,
127.4, 127.6, 128.7, 128.8 (10d, 26 arom. CH); 140.6,
143.5, 143.9, 145.7 (4s, 6 arom. C + 2 arom. CN); 155.9
(s, 2 O-CO-N); 171.5, 172.1 (2s, 4 CON). ESI-MS (m/z):
1089 (9, [M + K]+), 1073 (100, [M + Na]+). [α]25D: –18.9
(c 1.0, CHCl3). Anal. Calcd. for C64H70N6O8·0.5 H2O
(1060.30): C, 72.50; H, 6.75; N, 7.93. Found: C, 72.63; H,
6.53; N, 7.75.
Benzyl Trans-[(S)-1-(4-{(S)-2-[(Benzyloxycarbonyl)
amino]-6-(tert-butylamino)hexanoylamino}-1,4-bis(N-
methyl-N-phenylcarbamoyl)cyclohexylcarbamoyl)-5-
(tert-butylamino)pentyl]carbamate (trans-23d). Prepa-
red according to GP4; with trans-21 (100 mg, 0.29 mmol)
and Z-Lys(Boc)-OH (243 mg, 0.64 mmol) in CHCl3 (10
ml), 2 h, CC (SiO2, CH2Cl2/MeOH 15:1). Yield: 295 mg
(92%) of trans-23d. White powder; mp 190–191 °C. IR
(KBr): νmax 3327s, 3034w, 2959m, 2932m, 2865w, 1717s,
1659s, 1626s, 1593m, 1525s, 1454s, 1365s, 1250s, 1170s,
1101m, 1034m, 750m, 699s cm–1. 1H NMR (d6-DMSO):
δ 1.37 (18H, s, 2 Me3C); 1.24–1.70, 1.94–2.10 (12H + 8H,
2m, 4 CH2 + 2 CHCH2CH2CH2); 2.85–2.94 (4H, m, 2
CH2N); 3.93–4.01 (2H, m, 2 CHCH2); 5.00, 5.08 (4H, 2d,
J = 12.5 Hz, 2 CH2O); 6.72 (2H, br, 2 NH); 7.11–7.38
(22H, 4 Ph + 2 NH); 7.79 (2H, br, 2 NH). 13C NMR (d6-
DMSO): δ 22.7, 26.3, 26.8, 29.1, 31.5, 39.6 (6t, 2 (CH2)2C
+ 2 (CH2)4); 28.1 (q, 2 Me3C); 39.8 (q, 2 MeN); 54.2 (d, 2
NCHCO); 65.3 (t, 2 CH2O); 57.7 (s, (CH2)2C); 77.2 (s, 2
Me3C); 126.3, 127.0, 127.5, 128.1, 128.7 (5d, 20 arom.
CH); 136.9 (s, 2 arom. C); 145.5 (s, arom. 2 CN); 155.4,
156.0 (2s, 4 O-CO-N); 171.2, 172.1 (2s, 4 CON). ESI-MS
(m/z): 1143 (8, [M + K]+), 1127 (100, [M + Na]+). [α]25D:
–6.7 (c 0.5, MeOH). Anal. Calcd. for C60H80N8O12·0.5
H2O (1114.35): C, 64.67; H, 7.33; N, 10.06. Found: C,
64.47; H, 7.04; N, 9.80.
Trans-1,4-Bis(acetylamino)cyclohexane-1,4-dicar-
boxylic Acid bis(N-methyl-N-phenylamide) (trans-24).
Prepared according to GP4; with trans-21 (100 mg, 0.29
mmol) and acetic acid (52 mg, 50 ml, 0.87 mmol) in
CHCl3 (5 ml), 2 h, washing with MeOH. Yield: 127 mg
(94%) of trans-24. White powder (only soluble in
CF3CO2H); mp 144–145 °C. IR (KBr): νmax 3263m,
3063m, 2972w, 2926w, 1648s, 1592m, 1549s, 1493m,
1367s, 1297m, 1274w, 1083w, 1073w, 1025w, 771w,
706m cm–1. 1H NMR (CF3CO2D): δ 2.21–3.13 (14H, m, 2
MeCO + 2 CH2); 3.30 (6H, s, 2 MeN); 7.40–7.72 (10H,
m, 2 Ph). ESI-MS (m/z): 503 (14, [M + K]+), 487 (100, [M
+ Na]+).
Trans-1,4-Bis((S)-2-{[(9H-fluoren-9-yl)methoxy]car-
bonylamino}-4-methylpentanoylamino)cyclohexane-
1,4-dicarboxylic acid (trans-25c). To a solution of trans-
600 Acta Chim. Slov. 2009, 56, 591–602
Köttgen et al.:  Synthesis of Bis-Aminoazirines and their Application in Peptide Synthesis
23c (80 mg, 0.076 mmol) in THF (15 ml) was slowly ad-
ded an aqueous HCl-solution (32%, 6.4 ml), and the mix-
ture was stirred at r.t. for 24 h. Then, aqueous HCl (2M so-
lution, 10 ml) was added and the mixture was extracted
with Et2O (3 × 10 ml). After drying over MgSO4 and eva-
poration of the solvent, the residue was recrystallized
from acetone/hexane, yielding trans-25c (64 mg, 96%).
White powder; mp 171–173 °C. IR (KBr): νmax 3325s,
3065m, 2956s, 1719s, 1662s, 1525s, 1540m, 1338m,
1262s, 1108m, 1050m, 758m, 739m cm–1. 1H NMR
(CD3OD): δ 0.92, 0.95 (12H, 2d, J = 6.5 Hz, 2 Me2CH);
1.45–1.78, 1.91–2.20 (6H + 8H, 2m, 2 Me2CHCH2 + 2
(CH2)2C); 4.18–4.29, 4.40 (8H, m + d, J = 6.6 Hz, 2
CHCH2O + 2 NCHCO); 7.25–7.41, 7.60–7.83 (16H, 2m,
2 fluorenyl). 13C NMR (CD3OD): δ 22.0, 23.3 (2q, 2
Me2CH); 25.8 (d, 2 Me2CH); 27.7, 28.0 (2t, 2 (CH2)2C);
41.8 (t, 2 MeCHCH2); 48.4, 54.8 (2d, 2 CHCH2O + 2
NCHCO); 59.1 (s, 2 (CH2)2C); 67.8 (t, 2 CH2O); 120.8,
126.1, 126.2, 128.1, 128.6 (5d, 16 arom. CH); 142.5,
145.1, 145.4 (3s, 8 arom. C); 158.3 (s, 2 O-CO-N); 175.4,
176.9 (2s, 2 CON + 2 CO2). ESI-MS (m/z): 895 (100, [M
+ Na]+). [α]25D: –16.4 (c 1.0, acetone).
(9H-Fluoren-9-yl)methyl Trans-{(S)-1-[4-((S)-2-{[(9H-
Fluoren-9-yl)methoxy]carbonylamino}-4-methylpen-
tanoylamino)-1,4-bis[1-methyl-1-(N-methyl-N-
phenylcarbamoyl)ethylcarbamoyl]cyclohexylcarba-
moyl]-3-methylbutyl}carbamate (trans-26c). A solu-
tion of trans-25c (150 mg, 0.17 mmol) and aminoazirine 2
(63 mg, 0.36 mmol) in THF (10 ml) was stirred at r.t. for
48 h. Then, the solvent was evaporated and the residue
was purified by CC (SiO2, CH2Cl2/MeOH 20:1), yielding
149 mg (71%) of trans-26c. White powder; mp 203–204
°C. IR (KBr): νmax 3314s, 2953m, 2868w, 1718s, 1665s,
1654s, 1631s, 1593m, 1513s, 1494s, 1449m, 1393m,
1364m, 1259m, 1203m, 1088m, 1025m, 780w, 734m,
706m cm–1. 1H NMR (CD3OD): δ 0.99, 1.04 (12H, 2d, J =
6.4 Hz, 2 Me2CH); 1.39, 1.46 (12H, 2s, 2 Me2C);
1.55–2.10, 2.31–2.48 (12H + 2H, 2m, 2 MeCHCH2 + 2
(CH2)2C); 3.24 (6H, s, 2 MeN); 4.10–4.51 (8H, m, 2
CHCH2O + 2 NCHCO); 7.17–8.10 (32H, m, 2 Ph + 2
fluorenyl +6 NH). 13C NMR (CD3OD): δ 22.3, 23.1, 26.2,
26.4 (4q, 4 Me2C + 2 Me2CH); 25.9 (d, 2 Me2CH); 27.9,
27.9 (2t, 2 (CH2)2C); 41.1 (q, 2 MeN); 41.4 (t,
Me2CHCH2); 48.3 (d, 2 CHCH2O); 55.7 (d, 2 CHN); 68.0
(t, 2 CH2O); 120.9, 126.0, 126.2, 128.1, 128.2, 128.3,
128.8, 130.2 (8d, 26 arom. CH); 142.5, 145.1, 145.2 (3s, 8
arom. C + 2 arom. CN); 158.0 (s, 2 N-CO-O); 175.2,
175.4, 176.0 (3s, 6 CON). ESI-MS (m/z): 1243 (100, [M +
Na]+). [α]25D: –13.5 (c 1.0, acetone).
4. 5. X-Ray Crystal-Structure Determination
of cis-21 (see Figure 2).****
All measurements were made on a Nonius Kappa-
CCD area detector diffractometer55 using graphite-mo-
nochromated MoKa radiation (λ· 0.71073 Å) and an Ox-
ford Cryosystems Cryostream 700 cooler. Data reduction
was performed with HKL Denzo and Scalepack.56 The in-
tensities were corrected for Lorentz and polarization ef-
fects, but not for absorption. Equivalent reflections were
merged. Data collection and refinement parameters are gi-
ven below, and a view of the molecule is shown in Figure
2. The structure of cis-21 was solved by direct methods
using SIR92,57 which revealed the positions of all non-
hydrogen atoms. The non-hydrogen atoms were refined
anisotropically. All of the H-atoms were placed in geome-
trically calculated positions and refined using a riding mo-
del where each H-atom was assigned a fixed isotropic dis-
placement parameter with a value equal to 1.2Ueq of its
parent C-atom (1.5Ueq for the Me groups). Refinement of
the structure was carried out on F2 using full-matrix least-
squares procedures, which minimized the function
Σw(Fo2–Fc2)2. A correction for secondary extinction was
applied. Although the conformation of the molecule is
clearly defined, the refinement results are poor. This ap-
pears to be because of the nature of the crystals. Either
they are twinned or are intergrown, as the diffraction ima-
ges show evidence of interleaving lattices with many ref-
lections overlapping. Data recorded from several crystals
yielded similar results. An attempt to extract twinned data
was unsuccessful. The imprecise nature of the geometric
parameters means that it is inadvisable to attempt to draw
any far-reaching conclusions from a detailed analysis of
the geometrical parameters. Neutral atom scattering fac-
tors for non-H-atoms were taken from ref.,58a and the scat-
tering factors for H-atoms were taken from ref.59 Anoma-
lous dispersion effects were included in Fc;
60 the values
for ƒ ’ and ƒ ” were those of ref.58b The values of the mass
attenuation coefficients are those of ref.58c All calculations
were performed using the SHELXL9761 program.
Crystal data for cis-21: C22H24N4, M = 344.46, co-
lorless, prism, crystal dimensions 0.20 × 0.30 × 0.35 mm,
monoclinic, space group P21/c, Z = 4, a = 19.4051(6) Å, b
= 9.7739(3) Å, c = 10.1001(2) Å, β = 98.747(2)°, V =
1893.34(9) Å3, T = 160 K, Dx = 1.208 gcm
–3, μ(MoKα) =
0.0732 mm–1, scan type φ and ω, 2θ(max) = 60°, total ref-
lections measured 48208, symmetry independent reflec-
tions 5539, reflections with I > 2σ(I) 4123, reflections
used in refinement 5539, parameters refined 239, R(F) [I
> 2σ(I) reflections] = 0.1315, wR(F2) [all data] = 0.4719
(w = [σ2(Fo2) + (0.2P)2]–1, where P = (Fo2 + 2Fc2)/3),
goodness of fit 1.923, secondary extinction coefficient
0.17(4), final Δmax/σ 0.001, Δσ (max; min) = 0.50; –0.45 e
Å–3.
**** CCDC-704899 contains the supplementary crystallographic data
for this paper. These data can be obtained free of charge from the
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/
data_request/cif.
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Povzetek
Opisana je sinteza ‘cikloheksan-premostenih’ bis-(3-amino-2H-azirinov), cis- in trans-N,N’-dimetil-N,N’-difenil-1,7-
diazadispiro[2.2.2.2]deka-1,7-dien-2,8-diaminov iz ustreznih bis-thioamidov 20 z zaporednimi pretvorbami s COCl2,
1,4-diazabiciklo[2.2.2]oktanom in NaN3. Reakcije teh bis-azirinov z razli~nimi naravnimi α-amino kislinami so vodile
do peptid amidov 23. Hidroliza C-terminalnih amidnih skupin spojin 23c s slewde~im pripajanjem na Aib sinton 2,
2,2,N-trimetil-N-fenil-2H-azirin-3-amin, je pokazala uporabnost gradnikov 21 v sintezi peptidov. 
